About Veeva Systems Inc
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.veeva.com/medtech/
Frequently Asked Questions
What is the 52-week range for VEEV?
The 52-week high is $310.5 and the 52-week low is $148.05.
What is the P/E ratio for VEEV?
The Price to Earnings (P/E) ratio is 43.61.
What is the dividend yield for VEEV?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 14.00%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 29.34%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 4.63.
Analyst Recommendation Trends
Wall Street analyst consensus for VEEV over the last few months:
Latest VEEV News
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
Veeva Systems (VEEV) reached $273.25 at the closing of the latest trading day, reflecting a -3.08% change compared to its last close.
Jim Cramer Says Investors Who Bet AI Would Destroy Software Stocks ‘Blew Up’ — Salesforce, Veeva and Palantir Led Q3 Comeback: Stocks to Watch Ahead
Enterprise software's resurgence was a defining stock market story of the third quarter despite fears of AI negatively impacting their business, according to Jim Cramer.
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
Veeva Systems (VEEV) closed the most recent trading day at $281.93, moving 1.23% from the previous trading session.
AI Will Revolutionize Medicine. This Company Provides the Plumbing.
Veeva Systems is making that transformation happen. The Pleasanton, Calif.–based company develops software for biotechnology and pharmaceutical customers to manage everything from research and development and regulatory submissions to day-to-day commercial operations. Its software was originally built atop Salesforce but has since expanded to stand-alone applications.
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Uncover the latest developments among S&P500 stocks in today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
'HHS launches project to speed up clinical trials' - Axios
https://www.axios.com/2026/09/30/hhs-clinical-trials-redesign
Servier Adopts Veeva OpenData Globally to Scale AI
Veeva Systems (NYSE: VEEV) today announced that Servier is standardizing customer reference data across more than 80 countries with Veeva OpenData. Building on its global success with Veeva Link Key People, a leading French pharmaceutical company governed by a Foundation, is harmonizing customer reference data and creating a unified foundation to scale AI.
Veeva Systems: Same Old Story, Same Rating Once Again
Veeva Systems faces significant headwinds as Salesforce ends their partnership and competitive threats limit upside potential. See why VEEV stock is a hold.
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
Based on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Is Veeva Systems Stock Underperforming the Dow?
Veeva Systems has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Veeva Systems: Excellent Execution, But Upside Potential Has Waned (Rating Downgrade)
Veeva Systems was downgraded to neutral after a 40%+ rally as valuation looks stretched despite strong growth and Falcon AI demand. Click for more on VEEV stock.
Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know
Veeva Systems (VEEV) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session.
Stock Market Today: Dow Leads Charge Amid U.S.-Iran Peace Talks; Arista Networks Eyes Buy Point (Live Coverage)
Stock Market Today: The Dow Jones index rises Friday on U.S.-Iran peace hopes. Micron stock and Sandisk rally Friday.
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem.
Veeva (VEEV) Down 2.6% Since Last Earnings Report: Can It Rebound?
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
If You Invested $100 In Veeva Systems Stock 10 Years Ago, You Would Have This Much Today
Veeva Systems (NYSE:VEEV) has outperformed the market over the past 10 years by 7.41% on an annualized basis producing an average annual return of 21.03%. Currently, Veeva Systems has a market capitalization of $44.69
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients
In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major customer wins including Oxford Biomedica adopting Veeva Quality Cloud and Amgen planning a global deployment of Veeva Vault CRM. Together, these developments highlight Veeva’s push to embed agentic AI across clinical, safety, quality, and commercial workflows, reinforcing its role as an end-to-end software partner for life sciences...
Veeva Systems (VEEV) Could Be 29% Undervalued Following Its New AI Study Design Launch
Veeva Systems launches new AI study design agent Veeva Systems (VEEV) has unveiled Veeva Study Builder Agent, an AI tool that configures its EDC and Data Quality System directly from a clinical study protocol, aiming to streamline and standardize trial setup. Recent AI product launches and new client wins have arrived alongside a sharp 71.27% 90 day share price return and an 8.97% 30 day share price return for Veeva Systems, while the 1 year total shareholder return is slightly down 2.59%,...
EXCLUSIVE: AI Has A Blind Spot, Here Are 3 Overlooked Stocks
Jensen’s Allen Bond says investors may be overlooking Veeva, Verisk and Broadridge as AI reshapes software and business services.
Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year?
Doximity (DOCS), which calls itself the leading digital platform for U.S. medical professionals, has seen its stock fall steeply over the past year. Even after a rise over the past three months, the shares sit about 65% below their 52-week high. Management continued its repurchase program, allocating approximately $401 million over the latest twelve months. The test is whether it can keep that up through what it calls its AI investment year.
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day
Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol. By reusing an organization's existing standards and leveraging the CDISC Unified Study Definitions Model (USDM), the agent ensures faster, more deterministic study builds.
Quality Management System Software Market Forecasts Growth from $11.73B (2026) to $20.43B by 2031, Profiling Veeva Systems, Siemens, PTC, SAP, Oracle & 15 Others
The global Quality Management System (QMS) software market is projected to grow from USD 11.73 billion in 2026 to USD 20.43 billion by 2031, at an 11.7% CAGR. Growth is driven by cloud-based QMS platforms, AI-powered quality analytics, automated compliance workflows and integration with ERP, MES and PLM systems. SMEs are the fastest-growing customer segment, while document control and management holds the largest market share. North America leads the market, and Asia Pacific is the fastest-growi
These S&P500 stocks are moving in today's session
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing
VEEV launches Falcon Router to automate biopharma case routing, deepening AI integration across regulated life sciences workflows.
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva
Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and Company, and Regeneron. With more than 190 live customers and global commitments from 14 of the top 20 biopharmas, Vault CRM is the next generation of CRM, delivering new agentic and core capabilities to increase field productivity and effectiveness.
eClinical Solutions Market by Product, Application, Trial Phase, End User, Regulatory, AI, Growth, Market Size - Forecast to 2030
The global eClinical solutions market is projected to grow from USD 13.18 billion in 2025 to USD 25.22 billion by 2030, registering a 13.9% CAGR. Growth is driven by rising clinical trial costs, regulatory requirements, R&D investment, government funding, data standardization and adoption of innovative clinical research software. Data collection led the market in 2024, while pharmaceutical and biopharmaceutical companies were the largest end users. North America dominated due to advanced healthc
Pharmacovigilance Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)
The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, rising adverse event data, and adoption of AI, automation, NLP and cloud platforms. North America leads the market, while Asia-Pacific will grow fastest. Key players include Oracle, IQVIA, ArisGlobal, Parexel, ICON, Veeva Systems and RxLogix.Dublin, Sept. 23, 2026 (GLOBE NEWSWI
Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Veeva Expands Amgen Partnership With Global Vault CRM Rollout Plan
VEEV expands its decade-long Amgen partnership with a global Vault CRM rollout, reinforcing enterprise adoption and commercial subscription growth.
2 Growth Stocks to Add to Your Roster and 1 Facing Headwinds
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Veeva Introduces Falcon Router for Agentic Triage of All Reporting Channels
Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Router, an industry-specific agent to identify and route potential safety adverse event reports, product quality complaints, and medical inquiries to the correct teams with speed and consistency.
Veeva Launches AI Agent To Speed Up Safety And Medical Request Routing
Veeva Systems (NYSE:VEEV) today announced Veeva Falcon Router, an industry-specific agent to identify and route potential safety adverse event reports, product quality complaints, and medical inquiries to the correct
Trade Desk (TTD) Expands Healthcare Data Ties, Is The Stock Still Undervalued?
Trade Desk’s healthcare data push Trade Desk (TTD) is back in focus after expanding its integrations with healthcare data specialists Veeva Systems and IQVIA, giving pharma advertisers more granular campaign insights directly inside its advertising platform. Recent trading has been rough for Trade Desk, with the share price down 24.8% over the past 90 days and the year-to-date share price return declining 63.1%, while the 1-year total shareholder return is down 68.7%. This points to fading...
2 Profitable Stocks to Keep an Eye On and 1 We Ignore
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Veeva Systems (NYSE:VEEV) Combines Strong Growth With a High-Quality Technical Setup
VEEV pairs strong growth, elite profitability, and a debt-free balance sheet with a constructive technical setup, though rich valuation remains a risk.
2 Reasons to Like VEEV (and 1 Not So Much)
What a fantastic six months it’s been for Veeva Systems. Shares of the company have skyrocketed 43%, hitting $265. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Veeva Systems (VEEV) Just Flashed Golden Cross Signal: Do You Buy?
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Leading Biotech Selects Veeva Vault CRM Globally
Veeva Systems (NYSE: VEEV) today announced that Amgen plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more than a decade.
These S&P500 stocks are moving in today's pre-market session
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.
Veeva Systems Sees AI as Growth Engine Beyond Its $6B 2030 Revenue Target
Veeva Systems (NYSE:VEEV) is positioning artificial intelligence as an incremental growth opportunity beyond its previously stated goal of reaching $6 billion in revenue by 2030, according to executives speaking at a Wells Fargo healthcare technology event. Paul Shawah, Veeva’s EVP of Commercial St
Veeva Systems Unveils Falcon AI as Commercial Growth Gains Momentum
Veeva Systems (NYSE:VEEV) CFO Brian Van Wagener said the company is expanding its artificial intelligence roadmap while continuing to see broad-based growth across its life sciences software portfolio. Speaking at Citi’s Tech Conference, Van Wagener described Veeva as a vertical software provider f
Veeva Systems Inc. (VEEV) Presents at Citi's 2026 Global TMT Conference Transcript
Veeva Systems Inc. (VEEV) Citi's 2026 Global TMT Conference September 10, 2026 10:50 AM EDTCompany ParticipantsBrian Van Wagener - Chief Financial...
2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Michael Burry Remains Bullish on Veeva but Trimmed His Position. What This Means for VEEV Stock.
Michael Burry remains bullish on Veeva but trimmed his stake after shares jumped more than 15% on a fiscal second-quarter earnings beat and a raised 2027 outlook.
Software Rebound Extends Moat Index Gains
The S&P 500 gained 2.72% and reached a record high in August, with energy leading the market as crude prices rose. Read more here.
Why Is Veeva Systems (VEEV) Winning Big In AI For Biopharma?
Veeva Systems (NYSE: VEEV) announced that Regeneron and Biogen have adopted its AI powered Vault CRM suite globally. The company also introduced Veeva Falcon Safety, a new agentic safety operations product for biopharma clients. Both moves expand Veeva Systems' AI focused offering across commercial and safety workflows in life sciences. These updates highlight how AI heavy software is becoming core infrastructure for healthcare and biopharma workflows. This connects directly to a wider set...
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-14 | Schwenger Thomas D. | -1,000 | $265.2 | $265,200 |
| 2026-09-09 | Hung Priscilla | -750 | $261.0405 | $195,780 |
| 2026-09-01 | Wallach Matthew J | -460 | - | - |
| 2026-09-01 | Wallach Matthew J | +460 | - | - |
| 2026-09-01 | Ritter Gordon | -541 | - | - |
| 2026-09-01 | Ritter Gordon | +541 | - | - |
| 2026-09-01 | Ritter Gordon | +15,585 | - | - |
| 2026-09-01 | Ritter Gordon | -250,000 | - | - |
| 2026-09-01 | Hung Priscilla | -477 | - | - |
| 2026-09-01 | Hung Priscilla | +477 | - | - |
| 2026-09-01 | Cabral Timothy S | -477 | - | - |
| 2026-09-01 | Cabral Timothy S | +477 | - | - |
| 2026-09-01 | Hedley Mary Lynne | -477 | - | - |
| 2026-09-01 | Hedley Mary Lynne | +477 | - | - |
| 2026-09-01 | Carges Mark T | -493 | - | - |
| 2026-09-01 | Carges Mark T | +493 | - | - |
| 2026-09-01 | SEKHRI PAUL J | -460 | - | - |
| 2026-09-01 | SEKHRI PAUL J | +460 | - | - |
| 2026-09-01 | MOHR MARSHALL | -525 | - | - |
| 2026-09-01 | MOHR MARSHALL | +525 | - | - |
| 2026-08-27 | Schwenger Thomas D. | -10,000 | - | - |
| 2026-08-27 | Schwenger Thomas D. | -10,000 | $281.33 | $2,813,300 |
| 2026-08-27 | Schwenger Thomas D. | +10,000 | $154 | $1,540,000 |
| 2026-08-13 | Schwenger Thomas D. | -35,000 | - | - |
| 2026-08-13 | Schwenger Thomas D. | -1,819 | $251.028 | $456,620 |
| 2026-08-13 | Schwenger Thomas D. | -33,181 | $250.4403 | $8,309,860 |
| 2026-08-13 | Schwenger Thomas D. | +35,000 | $154 | $5,390,000 |
| 2026-08-13 | Schwenger Thomas D. | -1,000 | $241.91 | $241,910 |
| 2026-07-16 | Schwenger Thomas D. | -5,000 | $200 | $1,000,000 |
| 2026-07-01 | Zuppas Eleni Nitsa | -2,180 | - | - |
| 2026-07-01 | Zuppas Eleni Nitsa | +2,180 | - | - |
| 2026-07-01 | Van Wagener Brian | -1,635 | - | - |
| 2026-07-01 | Van Wagener Brian | -693 | $184.22 | $127,664 |
| 2026-07-01 | Van Wagener Brian | +1,635 | - | - |
| 2026-07-01 | Schwenger Thomas D. | -2,907 | - | - |
| 2026-07-01 | Schwenger Thomas D. | -1,117 | $184.22 | $205,774 |
| 2026-07-01 | Schwenger Thomas D. | +2,907 | - | - |
| 2026-07-01 | Kondath Vipin | -167 | - | - |
| 2026-07-01 | Kondath Vipin | -60 | $184.22 | $11,053 |
| 2026-07-01 | Kondath Vipin | +167 | - | - |
| 2026-07-01 | Faddis Jonathan | -1,635 | - | - |
| 2026-07-01 | Faddis Jonathan | -832 | $184.22 | $153,271 |
| 2026-07-01 | Faddis Jonathan | +1,635 | - | - |
| 2026-06-17 | Ritter Gordon | +2,164 | - | - |
| 2026-06-17 | Wallach Matthew J | +1,841 | - | - |
| 2026-06-17 | Hung Priscilla | +1,906 | - | - |
| 2026-06-17 | Cabral Timothy S | +1,906 | - | - |
| 2026-06-17 | Hedley Mary Lynne | +1,906 | - | - |
| 2026-06-17 | Carges Mark T | +1,970 | - | - |
| 2026-06-17 | SEKHRI PAUL J | +1,841 | - | - |
| 2026-06-17 | MOHR MARSHALL | +2,099 | - | - |
| 2026-06-01 | Ritter Gordon | -298 | - | - |
| 2026-06-01 | Ritter Gordon | +298 | - | - |
| 2026-06-01 | Wallach Matthew J | -253 | - | - |
| 2026-06-01 | Wallach Matthew J | +253 | - | - |
| 2026-06-01 | Hung Priscilla | -262 | - | - |
| 2026-06-01 | Hung Priscilla | +262 | - | - |
| 2026-06-01 | Cabral Timothy S | -262 | - | - |
| 2026-06-01 | Cabral Timothy S | +262 | - | - |
| 2026-06-01 | Hedley Mary Lynne | -262 | - | - |
| 2026-06-01 | Hedley Mary Lynne | +262 | - | - |
| 2026-06-01 | Carges Mark T | -271 | - | - |
| 2026-06-01 | Carges Mark T | +271 | - | - |
| 2026-06-01 | SEKHRI PAUL J | -253 | - | - |
| 2026-06-01 | SEKHRI PAUL J | +253 | - | - |
| 2026-06-01 | MOHR MARSHALL | -289 | - | - |
| 2026-06-01 | MOHR MARSHALL | +289 | - | - |
| 2026-04-30 | Hung Priscilla | -750 | $155.64 | $116,730 |
| 2026-04-10 | Hung Priscilla | -750 | $153.5 | $115,125 |
| 2026-04-07 | Zuppas Eleni Nitsa | 0 | - | - |
| 2026-04-07 | Zuppas Eleni Nitsa | 0 | - | - |
| 2026-04-07 | Van Wagener Brian | 0 | - | - |
| 2026-04-07 | Van Wagener Brian | 0 | - | - |
| 2026-04-07 | Schwenger Thomas D. | 0 | - | - |
| 2026-04-07 | Schwenger Thomas D. | 0 | - | - |
| 2026-04-07 | Kondath Vipin | 0 | - | - |
| 2026-04-07 | Kondath Vipin | 0 | - | - |
| 2026-04-07 | Faddis Jonathan | 0 | - | - |
| 2026-04-01 | Van Wagener Brian | -872 | - | - |
| 2026-04-01 | Van Wagener Brian | -370 | $172.74 | $63,914 |
| 2026-04-01 | Van Wagener Brian | +872 | - | - |
| 2026-04-01 | Schwenger Thomas D. | -2,043 | - | - |
| 2026-04-01 | Schwenger Thomas D. | -588 | $172.74 | $101,571 |
| 2026-04-01 | Schwenger Thomas D. | +2,043 | - | - |
| 2026-04-01 | Kondath Vipin | -103 | - | - |
| 2026-04-01 | Kondath Vipin | -2,500 | - | - |
| 2026-04-01 | Kondath Vipin | -43 | $172.74 | $7,428 |
| 2026-04-01 | Kondath Vipin | +103 | - | - |
| 2026-04-01 | Kondath Vipin | -914 | $172.74 | $157,884 |
| 2026-04-01 | Kondath Vipin | +2,500 | - | - |
| 2026-04-01 | Zuppas Eleni Nitsa | -1,498 | - | - |
| 2026-04-01 | Zuppas Eleni Nitsa | -7,500 | - | - |
| 2026-04-01 | Zuppas Eleni Nitsa | -538 | $172.74 | $92,934 |
| 2026-04-01 | Zuppas Eleni Nitsa | +1,498 | - | - |
| 2026-04-01 | Zuppas Eleni Nitsa | -3,464 | $172.74 | $598,371 |
| 2026-04-01 | Zuppas Eleni Nitsa | +7,500 | - | - |
| 2026-04-01 | Faddis Jonathan | -1,226 | - | - |
| 2026-04-01 | Faddis Jonathan | -7,500 | - | - |
| 2026-04-01 | Faddis Jonathan | -440 | $172.74 | $76,006 |
| 2026-04-01 | Faddis Jonathan | +1,226 | - | - |
| 2026-04-01 | Faddis Jonathan | -3,370 | $172.74 | $582,134 |
| 2026-04-01 | Faddis Jonathan | +7,500 | - | - |
| 2026-03-05 | Schwenger Thomas D. | -1,000 | $200 | $200,000 |
| 2026-03-01 | Hung Priscilla | -262 | - | - |
| 2026-03-01 | Hung Priscilla | +262 | - | - |
| 2026-03-01 | Cabral Timothy S | -262 | - | - |
| 2026-03-01 | Cabral Timothy S | +262 | - | - |
| 2026-03-01 | MOHR MARSHALL | -288 | - | - |
| 2026-03-01 | MOHR MARSHALL | +288 | - | - |
| 2026-03-01 | Wallach Matthew J | -253 | - | - |
| 2026-03-01 | Wallach Matthew J | +253 | - | - |
| 2026-03-01 | Ritter Gordon | -297 | - | - |
| 2026-03-01 | Ritter Gordon | +297 | - | - |
| 2026-03-01 | Hedley Mary Lynne | -262 | - | - |
| 2026-03-01 | Hedley Mary Lynne | +262 | - | - |
| 2026-03-01 | Carges Mark T | -271 | - | - |
| 2026-03-01 | Carges Mark T | +271 | - | - |
| 2026-03-01 | SEKHRI PAUL J | -253 | - | - |
| 2026-03-01 | SEKHRI PAUL J | +253 | - | - |
| 2026-01-13 | Schwenger Thomas D. | -1,000 | $231.43 | $231,430 |
| 2026-01-01 | Faddis Jonathan | -1,225 | - | - |
| 2026-01-01 | Faddis Jonathan | -483 | $223.23 | $107,820 |
| 2026-01-01 | Faddis Jonathan | +1,225 | - | - |
| 2026-01-01 | Van Wagener Brian | -871 | - | - |
| 2026-01-01 | Van Wagener Brian | -321 | $223.23 | $71,657 |
| 2026-01-01 | Van Wagener Brian | +871 | - | - |
| 2026-01-01 | Zuppas Eleni Nitsa | -1,498 | - | - |
| 2026-01-01 | Zuppas Eleni Nitsa | -581 | $223.23 | $129,697 |
| 2026-01-01 | Zuppas Eleni Nitsa | +1,498 | - | - |
| 2026-01-01 | Schwenger Thomas D. | -2,042 | - | - |
| 2026-01-01 | Schwenger Thomas D. | -631 | $223.23 | $140,858 |
| 2026-01-01 | Schwenger Thomas D. | +2,042 | - | - |
| 2026-01-01 | Kondath Vipin | -103 | - | - |
| 2026-01-01 | Kondath Vipin | -43 | $223.23 | $9,599 |
| 2026-01-01 | Kondath Vipin | +103 | - | - |
| 2025-12-10 | Ritter Gordon | +294 | - | - |
| 2025-12-10 | Ritter Gordon | -1,393 | - | - |
| 2025-12-02 | SEKHRI PAUL J | -2,491 | - | - |
| 2025-12-01 | Cabral Timothy S | -263 | - | - |
| 2025-12-01 | Cabral Timothy S | +263 | - | - |
| 2025-12-01 | Ritter Gordon | -298 | - | - |
| 2025-12-01 | Ritter Gordon | +298 | - | - |
| 2025-12-01 | Wallach Matthew J | -254 | - | - |
| 2025-12-01 | Wallach Matthew J | +254 | - | - |
| 2025-12-01 | Hung Priscilla | -263 | - | - |
| 2025-12-01 | Hung Priscilla | +263 | - | - |
| 2025-12-01 | Hedley Mary Lynne | -263 | - | - |
| 2025-12-01 | Hedley Mary Lynne | +263 | - | - |
| 2025-12-01 | Carges Mark T | -271 | - | - |
| 2025-12-01 | Carges Mark T | +271 | - | - |
| 2025-12-01 | SEKHRI PAUL J | -254 | - | - |
| 2025-12-01 | SEKHRI PAUL J | +254 | - | - |
| 2025-12-01 | MOHR MARSHALL | -289 | - | - |
| 2025-12-01 | MOHR MARSHALL | +289 | - | - |
| 2025-10-08 | Schwenger Thomas D. | -980 | - | - |
| 2025-10-07 | Zuppas Eleni Nitsa | -6,000 | - | - |
| 2025-10-07 | Zuppas Eleni Nitsa | -6,000 | $306.6156 | $1,839,694 |
| 2025-10-07 | Zuppas Eleni Nitsa | +6,000 | $135.49 | $812,940 |
| 2025-10-06 | Faddis Jonathan | -5,001 | - | - |
| 2025-10-06 | Faddis Jonathan | -720 | $298.12 | $214,646 |